The Role of the Financial Adviser in Valuing Pharmaceutical Industry Intellectual Property

BVResearch Pro
Willamette Insights
November 1, 2005
Robert Schweihs, ASA
Michel St. Martin

Access the Full Article

This article and its downloads are available with a subscription to:
Already a subscriber?  Login
This article is also available for purchase. (2,632 words)   Add to Cart >>
Need help? Contact us:
1-503-479-8200 ext 2 or sales@bvresources.com

Summary

The commercial development of a new prescription drug is an extremely costly and highly risky endeavor. Estimating the value of the new prescription drug intellectual property is also a difficult task. In a pharmaceutical industry product development ...
The Role of the Financial Adviser in Valuing Pharmaceutical Industry Intellectual Property
PDF, Size: 244 KB